Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in chemosensitivity between subcutaneous and pulmonary tumours.

K A Smith, A C Begg, J Denekamp

    European Journal of Cancer & Clinical Oncology
    |February 1, 1985
    PubMed
    Summary

    Tumour location significantly impacts cyclophosphamide (chemotherapy) effectiveness. Pulmonary tumours are more sensitive than subcutaneous ones, and their response cannot predict each other.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Calcification of the left auricle; report of a case.

    The New Zealand medical journal·2010
    Same author

    OBSERVATIONS ON THE VACCINE TREATMENT OF A SERIES OF CASES OF STAPHYLOCOCCIC INFECTIONS.

    British medical journal·2010
    Same author

    The intervertebral disc and low backache.

    The New Zealand medical journal·2010
    Same author

    Myelography in lumbar intervertebral disk lesions; a correlation with operative findings.

    The British journal of surgery·2010
    Same author

    Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor.

    Cancer chemotherapy and pharmacology·2007
    Same author

    Hypoxia in head and neck cancer: how much, how important?

    Head & neck·2005

    Area of Science:

    • Oncology
    • Pharmacology
    • Tumour Biology

    Background:

    • Cyclophosphamide is a widely used chemotherapy agent.
    • Tumour characteristics, including size and location, can influence treatment response.
    • Understanding factors affecting chemosensitivity is crucial for optimizing cancer therapy.

    Purpose of the Study:

    • To investigate the influence of tumour site (subcutaneous vs. pulmonary) on the chemosensitivity of murine tumours to cyclophosphamide.
    • To analyze the relationship between tumour size, growth phase, vascularization, and response to chemotherapy.

    Main Methods:

    • Murine tumour models were established in subcutaneous and lung sites.
    • Tumours were treated with cyclophosphamide across a range of sizes.
    • Tumour curability and chemosensitivity were assessed.

    Related Experiment Videos

  • Tumour growth dynamics, including vascularization and volume doubling time, were evaluated.

    • Main Results:

    • Tumour site significantly impacts chemosensitivity; pulmonary metastases are more sensitive than subcutaneous implants.
    • In the lungs, curability decreases with increasing tumour size.
    • Subcutaneous tumour chemosensitivity shows a complex pattern: initial sensitivity, decline during avascular growth, and recovery with vascularization.
    • No correlation was found between tumour volume doubling time and chemosensitivity.

    Conclusions:

    • The anatomical site of tumour growth markedly influences its response to cyclophosphamide.
    • Predicting the response of pulmonary metastases based on subcutaneous tumour studies is unreliable.
    • Tumour vascularization and growth phase play critical roles in determining chemosensitivity, particularly in subcutaneous models.